| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $722.8M | +7.8% | +10.4% |
| Cost of Revenue | $91.3M | +4.3% | +7.0% |
| Gross Profit | $631.6M | +8.3% | +10.9% |
| R&D Expense | $202.3M | +7.9% | +10.7% |
| SG&A Expense | $67.6M | +10.7% | +13.0% |
| Operating Income | $84.1M | +70.5% | +28.6% |
| Pre-tax Income | $97.5M | +48.7% | +49.8% |
| Income Tax | -$5.5M | -258.6% | -163.7% |
| Net Income | $103.0M | +65.9% | +82.6% |
| EPS (Basic) | $0.38 | +65.2% | +81.0% |
| EPS (Diluted) | $0.36 | +71.4% | +89.5% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $603.4M | -22.7% | -43.7% |
| Accounts Receivable | $260.6M | -22.4% | -20.4% |
| Current Assets | $2.47B | -6.5% | +5.6% |
| Total Assets | $3.28B | -1.4% | +9.6% |
| Current Liabilities | $1.49B | +6.5% | +13.1% |
| Total Liabilities | $4.11B |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $394.2M | +100.3% | — |
| Capital Expenditures | $28.2M | +26.6% | — |
| Investing Cash Flow | -$67.3M | +9.7% | — |
| Financing Cash Flow | -$492.9M | -342.6% | — |
| Free Cash Flow | $365.9M | +109.7% | — |
| +8.2% |
| Stockholders' Equity | -$831.3M | -24.3% | -2.9% |